文献速递临床试验与 GCP基础与转化研究

高压氧治疗促进糖尿病足慢性溃疡愈合的随机对照临床试验:研究方案

Randomized controlled clinical trial evaluating the efficacy of hyperbaric oxygen therapy in facilitating the healing of chronic foot ulcers in diabetic patients: the study protocol.
PubMed 文献 · Trials · 2020-09-29

本研究为在巴西开展的非盲随机对照试验方案,计划纳入120例Wagner 2–4级、病程超过1个月的糖尿病足慢性溃疡患者,按1:1随机分配接受标准治疗联合高压氧治疗或仅标准治疗。主要目的是评估高压氧治疗促进溃疡愈合的疗效,次要目的包括评估其减少截肢数量及改善生活质量的效果,主要和次要终点在1年随访时评估。

要点

  • 纳入Wagner 2–4级、病程超过1个月的糖尿病足慢性溃疡患者。
  • 高压氧组接受标准治疗联合高压氧治疗,对照组仅接受标准治疗。
  • 主要和次要终点在1年随访时评估,生活质量用SF-36问卷评估。

核心结论

  • 该研究方案旨在评估高压氧治疗促进糖尿病足溃疡愈合的疗效,并次要评估其减少截肢数量和改善生活质量的效果。

研究设计与样本

  • 非盲随机对照临床试验,在巴西Imperatriz市于2019至2020年开展,样本量120例,按1:1随机分配为高压氧组和对照组各60例。

关键数值与推荐

  • 纳入标准为糖尿病足慢性溃疡患者,溃疡分类为Wagner 2、3和4级,且持续超过1个月。
  • 高压氧组在入院时及第10、20、30、35次高压氧治疗后、6个月和1年时评估。
  • 对照组在入院时及第2、4、6、7周、6个月和1年时评估。
  • 两组均在入院时和随访3个月时填写SF-36生活质量问卷。

临床怎么用

  • 该方案为高压氧治疗辅助标准治疗促进糖尿病足溃疡愈合的疗效评估提供随机对照试验框架。

局限性

  • 该研究为非盲设计。
  • 试验为回顾性注册。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diabetic limb ulcers are highly prevalent and contribute to a significant increase in cost for the treatment of these patients in health services. However, healing of these wounds is a major health problem and may even lead to amputation. The primary aim of the current study is to evaluate the efficacy of hyperbaric oxygen therapy (HBOT) in facilitating the healing of diabetic foot ulcers, in addition to secondarily evaluating whether it reduces the number of amputations and improves the quality of life in these patients. METHODS: A non-blind randomized clinical study will be conducted in the city of Imperatriz, Maranhão state, Brazil, from 2019 to 2020, in diabetic patients with chronic foot ulcers (classified as Wagner grades 2, 3 and 4, persisting for more than 1 month). The outpatient follow-up for diabetic foot patients will be done at the Unified Health System, with a sample size of 120 patients (the randomization allocation will be 1:1, being 60 patients for each arm). Half of the patients will receive standard treatment, i.e. dressings, debridement, antibiotics and load relief, along with HBOT (HBOT group), and the other half will receive only standard treatment (control group). The patients of the HBOT group will be evaluated upon admission, after 10, 20, 30 and 35 HBOT sessions, and after 6 months and 1 year. The patients of the control group will also be evaluated at equivalent periods (upon admission, after 2, 4, 6 and 7 weeks, 6 months and 1 year). The SF-36 quality of life questionnaire will be filled upon admission and after 3 months of follow-up in both groups. The primary and secondary endpoints will be assessed with 1 year of follow-up. DISCUSSION: Diabetic foot ulcers are a highly prevalent complication of diabetes with serious consequences. A study to assess the efficacy of HBOT in healing the ulcers and reducing the rate of amputations in diabetic patients is justified, which will eventually aid in the development of guidelines for treating these ulcers. TRIAL REGISTRATION: Registration number RBR-7bd3xy . Registered on 17 July 2019-Retrospectively registered.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Lopes JRA, D'Agostino Dias M, Correa JA, et al. Randomized controlled clinical trial evaluating the efficacy of hyperbaric oxygen therapy in facilitating the healing of chronic foot ulcers in diabetic patients: the study protocol. Trials. 2020. PMID: 32993766. doi:10.1186/s13063-020-04757-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。